[ad_1]
Sanofi appoints new executive committee leader and announces future EUROAPI chairman
- Viviane Monges joins Sanofi as Chairman of the EUROAPI Supervisory Board
- Roy Papatheodorou is appointed as Executive Vice President, General Counsel and Head of Legal, Ethics and Business Integrity
- Brendan O’Callaghan is appointed as Executive Vice President and Head of Global Industrial Affairs
phosphorusAris (France) —— July 29, 2021 – Karen Linehan and Philippe Luscan, who led legal, ethical and business integrity (LEBI) and industrial affairs at Sanofi for the past 14 and 13 years, have decided to retire. Karen will retire on December 31, 2021, and Philippe will retire later in 2022. Sanofi has appointed Roy Papatheodorou and Brendan O’Callaghan to succeed them, respectively, to join the company’s executive committee.
In addition, Viviane Monges will join EUROAPI, a leading European company dedicated to the development, production and marketing of active pharmaceutical ingredients (API) in the future, as the independent non-executive chairman of the supervisory board.After EUROAPI transforms into a company, she will serve as chairman of the board of directors society anonymous, Comply with applicable corporate governance regulations.
Together, these appointments underscore the company’s strategy to further increase the diversity and cultural background of the executives leading Sanofi’s modernization.
“These New appointment, A sort of A mix of internal promotions and newcomers in our company, Bring three high qualified An international leader with world-class pharmaceutical expertse, and a team that is keen to participate in and lead large organizations. Brendan and Roy will be important members of our executive committee,” Sanofi CEO Paul Hudson said. “Also, Vivienne, and her real The international experience of working with companies in the private and public sectors will break new ground. As the chairman of the future French company, the company will become one of the world’s leading API companies.. I thank Philip and Karen for their many contributions over the years. “
Vivian nun, Independent non-executive chairman of the board of supervisors
The appointment of Viviane Monges is effective immediately. As a French national, Viviane’s career spans multiple industries. She is the Chief Financial Officer of Nestlé Business Excellence. Prior to this, she spent nearly 20 years leading the financial operations of three pharmaceutical companies. She served as the Group Chief Financial Officer of Galderma SA, a multinational dermatology company. She served as EMEA CFO and Global CFO of Novartis OTC Division. At Wyeth Pharmaceuticals/Pfizer, she served as chief financial officer…
The full story on Benzinga.com
[ad_2]
Source link
